State of Wyoming’s Stoke Therapeutics STOK Stock Holding History

State of Wyoming’s Portfolio STOK Stock Details STOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$219K	Sell	6,690 -6,572	-50%	-$211K	0.02%	947
2026 Q1	$432K	Buy	13,262 +12,152	+1,095%	+$399K	0.05%	417
2025 Q4	$35.2K	Sell	1,110 -6,734	-86%	-$202K	﹤0.01%	1617
2025 Q3	$184K	Buy	+7,844	New	+$134K	0.02%	1005
2022 Q2	–	Sell	-869	Closed	-$18K	–	2122
2022 Q1	$18K	Buy	869 +292	+51%	+$5.85K	0.01%	1470
2021 Q4	$14K	Buy	577 +96	+20%	+$2.29K	0.01%	1621
2021 Q3	$12K	Sell	481 -298	-38%	-$8.31K	0.01%	1010
2021 Q2	$26K	Buy	779 +454	+140%	+$16K	0.02%	882
2021 Q1	$13K	Buy	+325	New	+$18.5K	0.02%	365

Other funds holding STOK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

State of Wyoming's STOK Position: Q2 2026 in Review

State of Wyoming reduced its Stoke Therapeutics (STOK) stake by 50% in Q2 2026, selling an estimated $211K and leaving 6,690 shares worth $219K. The position accounts for 0.02% of the portfolio, ranked #947.

State of Wyoming first reported a position in STOK in Q1 2021 and has held it in 9 quarters since. The position peaked at $432K in Q1 2026. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

State of Wyoming held 6,690 shares of Stoke Therapeutics worth $219K as of Q2 2026.
State of Wyoming sold 6,572 Stoke Therapeutics shares in Q2 2026, an estimated $211K.
Stoke Therapeutics made up 0.02% of State of Wyoming's portfolio in Q2 2026, its #947 holding.
State of Wyoming first reported a position in Stoke Therapeutics in Q1 2021 and has held it in 9 quarters since.
State of Wyoming's Stoke Therapeutics position peaked at $432K in Q1 2026.
197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.